Identification of Two Novel Variants of the DMD Gene in Chinese Families with Duchenne Muscular Dystrophy

Identification of Two Novel Variants of the DMD Gene in Chinese Families with Duchenne Muscular Dystrophy

Jiangfen Wu,1 Lingyan Ren,2 Xinyi Huang,3 Li Hu,2 Liangliang Zhang,2 Dan Xie,1 Zhimin Li,4 Naijian Han,4 Shengwen Huang1,2,5 1GuiZhou University Medical College, Guiyang, Guizhou, People’s Republic of China; 2Prenatal Diagnosis Center, Guizhou Provincial People’s Hospital, Guiyang, People’s Republic...

Full description

Bibliographic Details
Main Authors:	Wu J, Ren L, Huang X, Hu L, Zhang L, Xie D, Li Z, Han N, Huang S
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-08-01
Series:	Pharmacogenomics and Personalized Medicine
Subjects:	dmd gene exon 48 exon 27 whole exome sequencing duchenne muscular dystrophy
Online Access:	https://www.dovepress.com/identification-of-two-novel-variants-of-the-dmd-gene-in-chinese-famili-peer-reviewed-fulltext-article-PGPM

Similar Items

Modern methods of therapy of Duchenne muscular dystrophy: literature review with a clinical case
by: S. B. Artemyeva, et al.
Published: (2024-01-01)

Possibility of exon skipping therapy for Duchenne muscular dystrophy in Russian patients: present and future
by: E. V. Zinina, et al.
Published: (2024-09-01)

Systemic administration of the antisense oligonucleotide NS‐089/NCNP‐02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial
by: Takami Ishizuka, et al.
Published: (2023-06-01)

A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review
by: Lam Chung Liang, et al.
Published: (2022-03-01)

Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
by: Elisabeth Le Rumeur
Published: (2015-07-01)

Efficacy and safety of Viltepso® in Duchenne muscular dystrophy: review of clinical studies
by: V. M. Suslov, et al.
Published: (2024-11-01)

Duchenne/Becker muscular dystrophy: A report on clinical, biochemical, and genetic study in Gujarat population, India
by: Mandava V Rao, et al.
Published: (2014-01-01)

Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach Distrofia muscular de Duchenne e Becker: abordagem molecular e imuno-histoquímica
by: Aline Andrade Freund, et al.
Published: (2007-03-01)

Molecular characterization and reclassification of a 1.18 Mbp DMD duplication following positive carrier screening for Duchenne/Becker muscular dystrophy
by: Cinthya J. Zepeda‐Mendoza, et al.
Published: (2022-07-01)

The analysis of DMD gene deletions by multiplex PCR in Indonesian DMD/BMD patients: the era of personalized medicine
by: Kristy Iskandar, et al.
Published: (2019-10-01)

A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20
by: Sara Mata López, et al.
Published: (2018-05-01)

Novel Partial Exon 51 Deletion in the Duchenne Muscular Dystrophy Gene Identified via Whole Exome Sequencing and Long-Read Whole-Genome Sequencing
by: Qianqian Li, et al.
Published: (2021-11-01)

DMD antisense oligonucleotide mediated exon skipping efficiency correlates with flanking intron retention time and target position within the exon
by: Remko Goossens, et al.
Published: (2023-12-01)

Casimersen (AMONDYS 45™): An Antisense Oligonucleotide for Duchenne Muscular Dystrophy
by: Milyard Assefa, et al.
Published: (2024-04-01)

Novel Cationic Carotenoid Lipids as Delivery Vectors of Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
by: Vassilia Partali, et al.
Published: (2012-01-01)

Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors
by: Michael Gapinske, et al.
Published: (2023-09-01)

The X‐linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45–47
by: Christopher R. Heier, et al.
Published: (2023-04-01)

Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy
by: Francesco Galli, et al.
Published: (2024-03-01)

Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
by: Cedric Happi Mbakam, et al.
Published: (2022-03-01)

Prime editing strategies to mediate exon skipping in DMD gene
by: Cedric Happi Mbakam, et al.
Published: (2023-05-01)

Access to novel therapies for Duchenne muscular dystrophy—Insights from expert treating physicians
by: Aravindhan Veerapandiyan, et al.
Published: (2024-09-01)

Mutation spectrum analysis of DMD gene in Indonesian Duchenne and Becker muscular dystrophy patients [version 3; peer review: 2 approved]
by: Kristy Iskandar, et al.
Published: (2023-11-01)

The golden retriever model of Duchenne muscular dystrophy
by: Joe N. Kornegay
Published: (2017-05-01)

Evaluation of cardiac functions in children with Duchenne Muscular Dystrophy: A prospective case-control study
by: Abdelrahim Abdrabou Sadek, et al.
Published: (2017-11-01)

Isolation and Characterization of Primary DMD Pig Muscle Cells as an <i>In Vitro</i> Model for Preclinical Research on Duchenne Muscular Dystrophy
by: Tina Donandt, et al.
Published: (2022-10-01)

Intellectual Ability in the Duchenne Muscular Dystrophy and Dystrophin Gene Mutation Location
by: Rasic Milic V., et al.
Published: (2014-12-01)

Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse
by: Nicolas Wein, et al.
Published: (2022-09-01)

In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment
by: Marika Faiella, et al.
Published: (2024-08-01)

Factors associated with the health-related quality of life among people with Duchenne muscular dystrophy: a study using the Health Utilities Index (HUI)
by: Shelagh M. Szabo, et al.
Published: (2022-06-01)

Orthopaedic Management in Duchenne Muscular Dystrophy
by: Uma Balachandran, BA, et al.
Published: (2025-02-01)

Networking to Optimize <i>Dmd</i> exon 53 Skipping in the Brain of <i>mdx52</i> Mouse Model
by: Mathilde Doisy, et al.
Published: (2023-12-01)

Advances in Nucleic Acid Drugs and Gene Therapies based on Animal Models of Duchenne Muscular Dystrophy
by: LIU Siyu, et al.
Published: (2024-12-01)

A New Approach to Assess Quality of Motion in Functional Task of Upper Limb in Duchenne Muscular Dystrophy
by: Wiktoria Wojnicz, et al.
Published: (2022-11-01)

Inflammation in Duchenne Muscular Dystrophy–Exploring the Role of Neutrophils in Muscle Damage and Regeneration
by: Ankita Tulangekar, et al.
Published: (2021-10-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

Long-Read Sequencing Revealed Extragenic and Intragenic Duplications of Exons 56–61 in DMD in an Asymptomatic Male and a DMD Patient
by: Ying Bai, et al.
Published: (2022-05-01)

A state-of-the-art review of tamoxifen as a potential therapeutic for duchenne muscular dystrophy
by: Valeria Botti, et al.
Published: (2022-11-01)

Experience of observing patients with Duchenne myopathy
by: L. I. Minaycheva, et al.
Published: (2023-12-01)

Duchenne muscular dystrophy in Saudi Arabia: a review of the current literature
by: Hitham Aldharee
Published: (2024-07-01)

Unique pattern of late gadolinium enhancement on cardiac magnetic resonance imaging in Duchenne muscular dystrophy
by: Madhusudan Ganigara, et al.
Published: (2016-01-01)